Kieffer E, Sabatier J, Koskas F, Bahnini A
Department of Vascular Surgery, Pitié-Salpétrière University Hospital, Paris, France.
J Vasc Surg. 1995 Feb;21(2):326-36; discussion 336-7. doi: 10.1016/s0741-5214(95)70273-3.
Few articles have dealt specifically with surgical management of innominate artery (IA) atherosclerotic occlusive disease. We herein present our early and long-term results in a large series of patients.
During a 20-year period (1974 to 1993) we operated on 148 patients with IA atherosclerotic occlusive disease. The mean age was 55.8 +/- 9.4 years. Approach was through a median sternotomy in 135 (91%) patients. Endarterectomy was performed in 32 (22%) patients, whereas 116 (78%) patients underwent bypass.
Eight (5.4%) patients died in the perioperative period (four of heart-related causes, two of hemorrhage, one each of pulmonary infection and multiorgan failure). There were five (3.4%) perioperative strokes (three ipsilateral, two contralateral) and three (2.0%) ipsilateral perioperative transient ischemic attacks. Ten (7%) patients were lost to follow-up. Mean follow-up was 77 (2 to 193) months. Thirty-three (24%) patients were monitored 10 or more years. There were 45 (35%) late deaths (19 from cardiovascular-related causes, 15 from cancer, 7 from other known causes, and 4 from unknown causes). Although 11 (8.5%) patients had late neurologic events, only one late stroke occurred in the contralateral hemisphere and no ipsilateral late strokes occurred. Sixteen (11%) patients had late myocardial infarctions, nine of which were lethal. Life-table analysis and perioperative events were used to calculate the probability of survival, which was 77.5% +/- 9.5% and 51.9% +/- 20.8% at 5 and 10 years, respectively, with a 4.4% annual mortality rate. The overall probability of freedom from any neurologic/ocular event was 88.8% +/- 6.2% and 80.4% +/- 11.9% at 5 and 10 years, respectively, with a 1.6% annual occurrence rate. The probability of freedom from ipsilateral neurologic/ocular event was 92.7% +/- 4.8% and 84.0% +/- 11.2% at 5 and 10 years, respectively, with a 1.4% annual occurrence rate. The probability of freedom from ipsilateral stroke was 98.6% +/- 1.9% at 5 and 10 years. The primary patency rate was 98.4% +/- 2.1% and 96.3% +/- 4.7% at 5 and 10 years, respectively. The probability of freedom from reoperation was 95.6% +/- 3.9% and 93.5% +/- 5.9% at 5 and 10 years, respectively.
Surgical reconstruction of IA atherosclerotic occlusive disease yields acceptable rates of perioperative complications and late mortality and excellent long-term patency and freedom from neurologic events and reoperation.
很少有文章专门论述无名动脉(IA)粥样硬化闭塞性疾病的外科治疗。我们在此展示我们在大量患者中的早期和长期结果。
在20年期间(1974年至1993年),我们对148例IA粥样硬化闭塞性疾病患者进行了手术。平均年龄为55.8±9.4岁。135例(91%)患者采用正中胸骨切开术入路。32例(22%)患者行内膜切除术,而116例(78%)患者接受了搭桥手术。
8例(5.4%)患者在围手术期死亡(4例因心脏相关原因,2例因出血,1例因肺部感染,1例因多器官功能衰竭)。有5例(3.4%)围手术期卒中(3例同侧,2例对侧)和3例(2.0%)同侧围手术期短暂性脑缺血发作。10例(7%)患者失访。平均随访时间为77(2至193)个月。33例(24%)患者接受了10年或更长时间的监测。有45例(35%)晚期死亡(19例因心血管相关原因,15例因癌症,7例因其他已知原因,4例因不明原因)。尽管11例(8.5%)患者发生了晚期神经系统事件,但仅1例晚期卒中发生在对侧半球,同侧未发生晚期卒中。16例(11%)患者发生了晚期心肌梗死,其中9例是致命的。采用生命表分析和围手术期事件来计算生存率,5年和10年的生存率分别为77.5%±9.5%和51.9%±20.8%,年死亡率为4.4%。5年和10年无任何神经/眼部事件的总体概率分别为88.8%±6.2%和80.4%±11.9%,年发生率为1.6%。5年和10年无同侧神经/眼部事件的概率分别为92.7%±4.8%和84.0%±11.2%,年发生率为1.4%。5年和10年无同侧卒中的概率为98.6%±1.9%。5年和10年的初次通畅率分别为98.4%±2.1%和96.3%±4.7%。5年和10年无需再次手术的概率分别为95.6%±3.9%和93.5%±5.9%。
IA粥样硬化闭塞性疾病的外科重建术围手术期并发症和晚期死亡率可接受,长期通畅率高,神经事件和再次手术发生率低。